Summary

"Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015" report is an essential source of information and analysis on the global insulin delivery devices market. The report identifies the key trends shaping and driving the dynamism in the global insulin delivery devices market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global insulin delivery devices sector.

Scope

-Annualized global insulin delivery devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
-Key categories covered in this report are insulin pumps, insulin pens and insulin syringes
-Analysis and review of the key events and milestones that will impact the future of the global insulin delivery devices market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
-Insightful review of key industry drivers, restraints and challenges which are likely to impact the global insulin delivery devices market in the long run.
-The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. Key companies covered include Becton, Dickinson and Company, Medtronic, F. Hoffmann La Roche, Novo Nordisk, Sanofi Aventis, Eli Lilly, and Animas Corporation
-Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
-The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by's team of industry experts.

Reasons to buy

-Develop business strategies by understanding the trends shaping and driving the global insulin delivery devices market.
-Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global insulin delivery devices market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

Table Of Contents

1.1 List of Tables 6
1.2 List of Figures 7
2 Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015 8
2.1 Executive Summary 8
3 Insulin Delivery Devices Technology Landscape 10
3.1 Overview 10
3.2 History 11
3.3 Emerging Trends 11
3.3.1 Artificial Pancreas 11
3.3.2 MEMS Technology for Insulin Delivery 11
3.3.3 Transdermal Delivery and Insulin Patch 11
3.3.4 Inhaled Insulin 12
3.3.5 Oral Insulin 12
4 Global Insulin Delivery Devices Market Characterization 13
4.1 Market Overview 13
4.2 Insulin Delivery Devices Market Size 13
4.3 Insulin Delivery Devices Market Forecast and CAGR 14
4.4 Insulin Syringes Market Forecast and CAGR 18
4.5 Insulin Pens Market Forecast and CAGR 20
4.6 Insulin Pumps Market Forecast and CAGR 22
4.7 Market Dynamics 24
4.7.1 Market Drivers 24
4.7.1.1 Large diabetic population worldwide driving insulin delivery devices market 24
4.7.1.2 Increasing ageing and obese population contribution to diabetes epidemic 24
4.7.1.3 Technological advancements will drive the insulin delivery devices market 24
4.7.2 Market Restraints 25
4.7.2.1 Low diagnosis rate 25
4.7.2.2 Low patient compliance 25
4.7.2.3 Reimbursement and overall cost is a restraint for insulin pens and pumps 25
4.8 Insulin Delivery Devices Cross Country Analysis 26
4.9 Insulin Delivery Devices Cross Segment Analysis 28
4.10 Opportunity and Unmet Need 30
4.11 Key Takeaway 32
5 Insulin Delivery Devices Competitive Landscape 33
5.1 Overview 33
5.2 Strategic Competitor Assessment 33
5.3 Insulin Delivery Devices Company Shares 35
5.3.1 Becton, Dickinson and Company 35
5.3.2 Medtronic 35
5.3.3 Novo Nordisk 36
5.3.4 Others 36
5.3.4.1 Insulet Corporation 36
5.3.4.2 NiliMEDIX 36
5.3.4.3 Medingo Ltd. 37
5.3.4.4 Debiotech S.A 37
5.3.4.5 Phluid Corporation 37
5.3.4.6 Ratio Inc. 37
5.3.4.7 Insuline Medical Ltd. 37
5.3.4.8 Aradigm Corporation 37
5.3.4.9 MannKind Corporation 38
5.3.4.10 Altea Therapeutics Corporation 38
5.4 Key Takeaway 38
6 Insulin Delivery Devices Pipeline Products 39
6.1 Overview 39
6.2 Strategic Pipeline Assessment 39
6.3 Insulin Delivery Devices-Clinical Pipeline by Mode of Insulin Delivery 42
6.4 Insulin Delivery Devices-Pipeline by Clinical Phase of Development 43
6.5 Global Insulin Delivery Devices Pipeline Product Summary 44
6.6 Insulin Delivery Devices-Promising Devices under Clinical Development 45
6.6.1 Closed-loop diabetes management system 45
6.6.1.1 Product Status 45
6.6.1.2 Product Description 45
6.6.2 Paradigm Veo System 46
6.6.2.1 Product Status 46
6.6.2.2 Product Description 46
6.6.3 AERx insulin Diabetes Management System 47
6.6.3.1 Product Status 47
6.6.3.2 Product Description 47
6.6.3.3 Clinical Trial One 48
6.6.3.4 Clinical Trial Two 49
6.6.3.5 Clinical Trial Three 50
6.7 Key Takeaway 51
7 Insulin Delivery Devices-Future Market Competition 52
7.1 Strategic Competitor Assessment 53
8 Reimbursement for Insulin Delivery Devices 54
9 Appendix 56
9.1 Market Definitions 56
9.1.1 Insulin Delivery 56
9.1.1.1 Insulin Pens 56
9.1.1.2 Insulin Pumps 57
9.1.1.3 Insulin Syringes 57
9.1.1.4 Traditional Insulin Pump Accessories 57
9.2 Abbreviations 57
9.3 Research Methodology 58
9.4 Secondary Research 59
9.5 Primary Research 59
9.6 Models 60
9.7 Forecasts 60
9.8 Expert Panels 60
9.9  Consulting 61
9.10 Contact Us 61
9.11 Disclaimer 61

1.1 List Of Tables
Table 1: Anesthesia and Respiratory Devices, Global, Overall Revenue ($ m), Historic, 2000-2008 36
Table 2: Anesthesia and Respiratory Devices, Global, Overall Revenue ($ m), Forecast, 2008-2015 38
Table 3: Anesthesia and Respiratory Devices, Global, Category Volume (Units), Historic, 2000-2008 40
Table 4: Anesthesia and Respiratory Devices, Global, Category Volume (Units), Forecast, 2008-2015 42
Table 5: Anesthesia and Respiratory Devices, Global, Cross-Category Analysis, 2000-2015 44
Table 6: Anesthesia and Respiratory Devices, Global, Company share by Revenue ($ m), 2007-2008 46
Table 7: Anesthesia and Respiratory Devices, Cross Country Comparison, 2000-2015 48
Table 8: Anesthesia and Respiratory Devices, US, Overall Revenue ($ m), Historic, 2000-2008 50
Table 9: Anesthesia and Respiratory Devices, US, Overall Revenue ($ m), Forecast, 2008-2015 52
Table 10: Anesthesia and Respiratory Devices, US, Category Volume (Units), Historic, 2000-2008 53
Table 11: Anesthesia and Respiratory Devices, US, Category Volume (Units), Forecast, 2008-2015 54
Table 12: Anesthesia and Respiratory Devices, US, Portfolio Analysis, 2000-2015 56
Table 13: Anesthesia Disposables, US, Distribution Share by Revenue ($ m), 2007-2008 57
Table 14: Anesthesia Machines, US, Distribution Share by Revenue ($ m), 2007-2008 57
Table 15: Respiratory Devices, US, Distribution Share by Revenue ($ m), 2007-2008 58
Table 16: Respiratory Disposables, US, Distribution Share by Revenue ($ m), 2007-2008 58
Table 17: Respiratory Measurement Devices, US, Distribution Share by Revenue ($ m), 2007-2008 59
Table 18: Sleep Apnea Diagnostic Systems, US, Distribution Share by Revenue ($ m), 2007-2008 59
Table 19: Anesthesia and Respiratory Devices, US, Company Share by Revenue ($ m), 2008-2008 60
Table 20: Anesthesia Disposables, US, Company Share by Revenue ($ m), 2007-2008 62
Table 21: Anesthesia Machines, US, Company Share by Revenue ($ m), 2007-2008 63
Table 22: Respiratory Devices, US, Company Share by Revenue ($ m), 2007-2008 64
Table 23: Respiratory Disposables, US, Company Share by Revenue ($ m), 2007-2008 66
Table 24: Respiratory Measurement Devices, US, Company Share by Revenue ($ m), 2007-2008 67
Table 25: Sleep Apnea Diagnostic Systems, US, Company Share by Revenue ($ m), 2007-2008 68
Table 26: Anesthesia and Respiratory Devices, Japan, Overall Revenue ($ m), Historic, 2000-2008 70
Table 27: Anesthesia and Respiratory Devices, Japan, Overall Revenue ($ m), Forecast, 2008-2015 72
Table 28: Anesthesia and Respiratory Devices, Japan, Category Volume (Units), Historic, 2000-2008 73
Table 29: Anesthesia and Respiratory Devices, Japan, Category Volume (Units), Forecast, 2008-2015 74
Table 30: Anesthesia and Respiratory Devices, Japan, Portfolio Analysis, 2000-2015 76
Table 31: Anesthesia Disposables, Japan, Distribution Share by Revenue ($ m), 2007-2008 77
Table 32: Anesthesia Machines, Japan, Distribution Share by Revenue ($ m), 2007-2008 77
Table 33: Respiratory Devices, Japan, Distribution Share by Revenue ($ m), 2007-2008 78
Table 34: Respiratory Disposables, Japan, Distribution Share by Revenue ($ m), 2007-2008 78
Table 35: Respiratory Measurement Devices, Japan, Distribution Share by Revenue ($ m), 2007-2008 79
Table 36: Sleep Apnea Diagnostic Systems, Japan, Distribution Share by Revenue ($ m), 2007-2008 79
Table 37: Anesthesia and Respiratory Devices, Japan, Company Share by Revenue ($ m), 2008-2008 80
Table 38: Anesthesia Disposables, Japan, Company Share by Revenue ($ m), 2007-2008 82
Table 39: Anesthesia Machines, Japan, Company Share by Revenue ($ m), 2007-2008 84
Table 40: Respiratory Devices, Japan, Company Share by Revenue ($ m), 2007-2008 85
Table 41: Respiratory Disposables, Japan, Company Share by Revenue ($ m), 2007-2008 87
Table 42: Respiratory Measurement Devices, Japan, Company Share by Revenue ($ m), 2007-2008 89
Table 43: Sleep Apnea Diagnostic Systems, Japan, Company Share by Revenue ($ m), 2007-2008 90
Table 44: Anesthesia and Respiratory Devices, Germany, Overall Revenue ($ m), Historic, 2000-2008 92
Table 45: Anesthesia and Respiratory Devices, Germany, Overall Revenue ($ m), Forecast, 2008-2015 94
Table 46: Anesthesia and Respiratory Devices, Germany, Category Volume (Units), Historic, 2000-2008 95
Table 47: Anesthesia and Respiratory Devices, Germany, Category Volume (Units), Forecast, 2008-2015 96
Table 48: Anesthesia and Respiratory Devices, Germany, Portfolio Analysis, 2000-2015 98
Table 49: Anesthesia Disposables, Germany, Distribution Share by Revenue ($ m), 2007-2008 99
Table 50: Anesthesia Machines, Germany, Distribution Share by Revenue ($ m), 2007-2008 99
Table 51: Respiratory Devices, Germany, Distribution Share by Revenue ($ m), 2007-2008 100
Table 52: Respiratory Disposables, Germany, Distribution Share by Revenue ($ m), 2007-2008 100
Table 53: Respiratory Measurement Devices, Germany, Distribution Share by Revenue ($ m), 2007-2008 101
Table 54: Sleep Apnea Diagnostic Systems, Germany, Distribution Share by Revenue ($ m), 2007-2008 101
Table 55: Anesthesia and Respiratory Devices, Germany, Company Share by Revenue ($ m), 2008-2008 102
Table 56: Anesthesia Disposables, Germany, Company Share by Revenue ($ m), 2007-2008 103
Table 57: Anesthesia Machines, Germany, Company Share by Revenue ($ m), 2007-2008 104
Table 58: Respiratory Devices, Germany, Company Share by Revenue ($ m), 2007-2008 105
Table 59: Respiratory Disposables, Germany, Company Share by Revenue ($ m), 2007-2008 107
Table 60: Respiratory Measurement Devices, Germany, Company Share by Revenue ($ m), 2007-2008 108
Table 61: Sleep Apnea Diagnostic Systems, Germany, Company Share by Revenue ($ m), 2007-2008 110
Table 62: Anesthesia and Respiratory Devices, China, Overall Revenue ($ m), Historic, 2000-2008 113
Table 63: Anesthesia and Respiratory Devices, China, Overall Revenue ($ m), Forecast, 2008-2015 115
Table 64: Anesthesia and Respiratory Devices, China, Category Volume (Units), Historic, 2000-2008 116
Table 65: Anesthesia and Respiratory Devices, China, Category Volume (Units), Forecast, 2008-2015 117
Table 66: Anesthesia and Respiratory Devices, China, Portfolio Analysis, 2000-2015 118
Table 67: Anesthesia Disposables, China, Distribution Share by Revenue ($ m), 2007-2008 119
Table 68: Anesthesia Machines, China, Distribution Share by Revenue ($ m), 2007-2008 119
Table 69: Respiratory Devices, China, Distribution Share by Revenue ($ m), 2007-2008 120
Table 70: Respiratory Disposables, China, Distribution Share by Revenue ($ m), 2007-2008 120
Table 71: Respiratory Measurement Devices, China, Distribution Share by Revenue ($ m), 2007-2008 121
Table 72: Sleep Apnea Diagnostic Systems, China, Distribution Share by Revenue ($ m), 2007-2008 121
Table 73: Anesthesia and Respiratory Devices, China, Company Share by Revenue ($ m), 2008-2008 122
Table 74: Anesthesia Disposables, China, Company Share by Revenue ($ m), 2007-2008 123
Table 75: Anesthesia Machines, China, Company Share by Revenue ($ m), 2007-2008 124
Table 76: Respiratory Devices, China, Company Share by Revenue ($ m), 2007-2008 126
Table 77: Respiratory Disposables, China, Company Share by Revenue ($ m), 2007-2008 128
Table 78: Respiratory Measurement Devices, China, Company Share by Revenue ($ m), 2007-2008 129
Table 79: Sleep Apnea Diagnostic Systems, China, Company Share by Revenue ($ m), 2007-2008 130
Table 80: Anesthesia and Respiratory Devices, France, Overall Revenue ($ m), Historic, 2000-2008 132
Table 81: Anesthesia and Respiratory Devices, France, Overall Revenue ($ m), Forecast, 2008-2015 134
Table 82: Anesthesia and Respiratory Devices, France, Category Volume (Units), Historic, 2000-2008 135
Table 83: Anesthesia and Respiratory Devices, France, Category Volume (Units), Forecast, 2008-2015 136
Table 84: Anesthesia and Respiratory Devices, France, Portfolio Analysis, 2000-2015 137
Table 85: Anesthesia Disposables, France, Distribution Share by Revenue ($ m), 2007-2008 138
Table 86: Anesthesia Machines, France, Distribution Share by Revenue ($ m), 2007-2008 138
Table 87: Respiratory Devices, France, Distribution Share by Revenue ($ m), 2007-2008 139
Table 88: Respiratory Disposables, France, Distribution Share by Revenue ($ m), 2007-2008 139
Table 89: Respiratory Measurement Devices, France, Distribution Share by Revenue ($ m), 2007-2008 140
Table 90: Sleep Apnea Diagnostic Systems, France, Distribution Share by Revenue ($ m), 2007-2008 140
Table 91: Anesthesia and Respiratory Devices, France, Company Share by Revenue ($ m), 2008-2008 141
Table 92: Anesthesia Disposables, France, Company Share by Revenue ($ m), 2007-2008 142
Table 93: Anesthesia Machines, France, Company Share by Revenue ($ m), 2007-2008 143
Table 94: Respiratory Devices, France, Company Share by Revenue ($ m), 2007-2008 144
Table 95: Respiratory Disposables, France, Company Share by Revenue ($ m), 2007-2008 146
Table 96: Respiratory Measurement Devices, France, Company Share by Revenue ($ m), 2007-2008 147
Table 97: Sleep Apnea Diagnostic Systems, France, Company Share by Revenue ($ m), 2007-2008 149
Table 98: Anesthesia and Respiratory Devices, UK, Overall Revenue ($ m), Historic, 2000-2008 151
Table 99: Anesthesia and Respiratory Devices, UK, Overall Revenue ($ m), Forecast, 2008-2015 153
Table 100: Anesthesia and Respiratory Devices, UK, Category Volume (Units), Historic, 2000-2008 154
Table 101: Anesthesia and Respiratory Devices, UK, Category Volume (Units), Forecast, 2008-2015 155
Table 102: Anesthesia and Respiratory Devices, UK, Portfolio Analysis, 2000-2015 156
Table 103: Anesthesia Disposables, UK, Distribution Share by Revenue ($ m), 2007-2008 157
Table 104: Anesthesia Machines, UK, Distribution Share by Revenue ($ m), 2007-2008 157
Table 105: Respiratory Devices, UK, Distribution Share by Revenue ($ m), 2007-2008 158
Table 106: Respiratory Disposables, UK, Distribution Share by Revenue ($ m), 2007-2008 158
Table 107: Respiratory Measurement Devices, UK, Distribution Share by Revenue ($ m), 2007-2008 159
Table 108: Sleep Apnea Diagnostic Systems, UK, Distribution Share by Revenue ($ m), 2007-2008 159
Table 109: Anesthesia and Respiratory Devices, UK, Company Share by Revenue ($ m), 2008-2008 161
Table 110: Anesthesia Disposables, UK, Company Share by Revenue ($ m), 2007-2008 162
Table 111: Anesthesia Machines, UK, Company Share by Revenue ($ m), 2007-2008 163
Table 112: Respiratory Devices, UK, Company Share by Revenue ($ m), 2007-2008 164
Table 113: Respiratory Disposables, UK, Company Share by Revenue ($ m), 2007-2008 166
Table 114: Respiratory Measurement Devices, UK, Company Share by Revenue ($ m), 2007-2008 167
Table 115: Sleep Apnea Diagnostic Systems, UK, Company Share by Revenue ($ m), 2007-2008 168
Table 116: Anesthesia and Respiratory Devices, India, Overall Revenue ($ m), Historic, 2000-2008 170
Table 117: Anesthesia and Respiratory Devices, India, Overall Revenue ($ m), Forecast, 2008-2015 172
Table 118: Anesthesia and Respiratory Devices, India, Category Volume (Units), Historic, 2000-2008 173
Table 119: Anesthesia and Respiratory Devices, India, Category Volume (Units), Forecast, 2008-2015 174
Table 120: Anesthesia and Respiratory Devices, India, Portfolio Analysis, 2000-2015 175
Table 121: Anesthesia Disposables, India, Distribution Share by Revenue ($ m), 2007-2008 176
Table 122: Anesthesia Machines, India, Distribution Share by Revenue ($ m), 2007-2008 176
Table 123: Respiratory Devices, India, Distribution Share by Revenue ($ m), 2007-2008 177
Table 124: Respiratory Disposables, India, Distribution Share by Revenue ($ m), 2007-2008 177
Table 125: Respiratory Measurement Devices, India, Distribution Share by Revenue ($ m), 2007-2008 178
Table 126: Sleep Apnea Diagnostic Systems, India, Distribution Share by Revenue ($ m), 2007-2008 178
Table 127: Anesthesia and Respiratory Devices, India, Company Share by Revenue ($ m), 2008-2008 179
Table 128: Anesthesia Disposables, India, Company Share by Revenue ($ m), 2007-2008 180
Table 129: Anesthesia Machines, India, Company Share by Revenue ($ m), 2007-2008 181
Table 130: Respiratory Devices, India, Company Share by Revenue ($ m), 2007-2008 182
Table 131: Respiratory Disposables, India, Company Share by Revenue ($ m), 2007-2008 184
Table 132: Respiratory Measurement Devices, India, Company Share by Revenue ($ m), 2007-2008 185
Table 133: Sleep Apnea Diagnostic Systems, India, Company Share by Revenue ($ m), 2007-2008 187
Table 134: Anesthesia and Respiratory Devices, Italy, Overall Revenue ($ m), Historic, 2000-2008 189
Table 135: Anesthesia and Respiratory Devices, Italy, Overall Revenue ($ m), Forecast, 2008-2015 191
Table 136: Anesthesia and Respiratory Devices, Italy, Category Volume (Units), Historic, 2000-2008 192
Table 137: Anesthesia and Respiratory Devices, Italy, Category Volume (Units), Forecast, 2008-2015 193
Table 138: Anesthesia and Respiratory Devices, Italy, Portfolio Analysis, 2000-2015 194
Table 139: Anesthesia Disposables, Italy, Distribution Share by Revenue ($ m), 2007-2008 195
Table 140: Anesthesia Machines, Italy, Distribution Share by Revenue ($ m), 2007-2008 195
Table 141: Respiratory Devices, Italy, Distribution Share by Revenue ($ m), 2007-2008 196
Table 142: Respiratory Disposables, Italy, Distribution Share by Revenue ($ m), 2007-2008 196
Table 143: Respiratory Measurement Devices, Italy, Distribution Share by Revenue ($ m), 2007-2008 197
Table 144: Sleep Apnea Diagnostic Systems, Italy, Distribution Share by Revenue ($ m), 2007-2008 197
Table 145: Anesthesia and Respiratory Devices, Italy, Company Share by Revenue ($ m), 2008-2008 198
Table 146: Anesthesia Disposables, Italy, Company Share by Revenue ($ m), 2007-2008 199
Table 147: Anesthesia Machines, Italy, Company Share by Revenue ($ m), 2007-2008 200
Table 148: Respiratory Devices, Italy, Company Share by Revenue ($ m), 2007-2008 202
Table 149: Respiratory Disposables, Italy, Company Share by Revenue ($ m), 2007-2008 204
Table 150: Respiratory Measurement Devices, Italy, Company Share by Revenue ($ m), 2007-2008 206
Table 151: Sleep Apnea Diagnostic Systems, Italy, Company Share by Revenue ($ m), 2007-2008 208
Table 152: Anesthesia and Respiratory Devices, Spain, Overall Revenue ($ m), Historic, 2000-2008 211
Table 153: Anesthesia and Respiratory Devices, Spain, Overall Revenue ($ m), Forecast, 2008-2015 213
Table 154: Anesthesia and Respiratory Devices, Spain, Category Volume (Units), Historic, 2000-2008 214
Table 155: Anesthesia and Respiratory Devices, Spain, Category Volume (Units), Forecast, 2008-2015 215
Table 156: Anesthesia and Respiratory Devices, Spain, Portfolio Analysis, 2000-2015 216
Table 157: Anesthesia Disposables, Spain, Distribution Share by Revenue ($ m), 2007-2008 217
Table 158: Anesthesia Machines, Spain, Distribution Share by Revenue ($ m), 2007-2008 217
Table 159: Respiratory Devices, Spain, Distribution Share by Revenue ($ m), 2007-2008 218
Table 160: Respiratory Disposables, Spain, Distribution Share by Revenue ($ m), 2007-2008 218
Table 161: Respiratory Measurement Devices, Spain, Distribution Share by Revenue ($ m), 2007-2008 219
Table 162: Sleep Apnea Diagnostic Systems, Spain, Distribution Share by Revenue ($ m), 2007-2008 219
Table 163: Anesthesia and Respiratory Devices, Spain, Company Share by Revenue ($ m), 2008-2008 220
Table 164: Anesthesia Disposables, Spain, Company Share by Revenue ($ m), 2007-2008 221
Table 165: Anesthesia Machines, Spain, Company Share by Revenue ($ m), 2007-2008 223
Table 166: Respiratory Devices, Spain, Company Share by Revenue ($ m), 2007-2008 224
Table 167: Respiratory Disposables, Spain, Company Share by Revenue ($ m), 2007-2008 226
Table 168: Respiratory Measurement Devices, Spain, Company Share by Revenue ($ m), 2007-2008 228
Table 169: Sleep Apnea Diagnostic Systems, Spain, Company Share by Revenue ($ m), 2007-2008 230
Table 170: Anesthesia and Respiratory Devices, Canada, Overall Revenue ($ m), Historic, 2000-2008 233
Table 171: Anesthesia and Respiratory Devices, Canada, Overall Revenue ($ m), Forecast, 2008-2015 235
Table 172: Anesthesia and Respiratory Devices, Canada, Category Volume (Units), Historic, 2000-2008 236
Table 173: Anesthesia and Respiratory Devices, Canada, Category Volume (Units), Forecast, 2008-2015 237
Table 174: Anesthesia and Respiratory Devices, Canada, Portfolio Analysis, 2000-2015 238
Table 175: Anesthesia Disposables, Canada, Distribution Share by Revenue ($ m), 2007-2008 239
Table 176: Anesthesia Machines, Canada, Distribution Share by Revenue ($ m), 2007-2008 239
Table 177: Respiratory Devices, Canada, Distribution Share by Revenue ($ m), 2007-2008 240
Table 178: Respiratory Disposables, Canada, Distribution Share by Revenue ($ m), 2007-2008 240
Table 179: Respiratory Measurement Devices, Canada, Distribution Share by Revenue ($ m), 2007-2008 241
Table 180: Sleep Apnea Diagnostic Systems, Canada, Distribution Share by Revenue ($ m), 2007-2008 241
Table 181: Anesthesia and Respiratory Devices, Canada, Company Share by Revenue ($ m), 2008-2008 242
Table 182: Anesthesia Disposables, Canada, Company Share by Revenue ($ m), 2007-2008 244
Table 183: Anesthesia Machines, Canada, Company Share by Revenue ($ m), 2007-2008 246
Table 184: Respiratory Devices, Canada, Company Share by Revenue ($ m), 2007-2008 247
Table 185: Respiratory Disposables, Canada, Company Share by Revenue ($ m), 2007-2008 249
Table 186: Respiratory Measurement Devices, Canada, Company Share by Revenue ($ m), 2007-2008 250
Table 187: Sleep Apnea Diagnostic Systems, Canada, Company Share by Revenue ($ m), 2007-2008 252
Table 188: Anesthesia and Respiratory Devices, Australia, Overall Revenue ($ m), Historic, 2000-2008 254
Table 189: Anesthesia and Respiratory Devices, Australia, Overall Revenue ($ m), Forecast, 2008-2015 256
Table 190: Anesthesia and Respiratory Devices, Australia, Category Volume (Units), Historic, 2000-2008 257
Table 191:    Anesthesia and Respiratory Devices, Australia, Category Volume (Units), Forecast, 2008-2015 258
Table 192: Anesthesia and Respiratory Devices, Australia, Portfolio Analysis, 2000-2015 259
Table 193: Anesthesia Disposables, Australia, Distribution Share by Revenue ($ m), 2007-2008 260
Table 194: Anesthesia Machines, Australia, Distribution Share by Revenue ($ m), 2007-2008 260
Table 195: Respiratory Devices, Australia, Distribution Share by Revenue ($ m), 2007-2008 261
Table 196: Respiratory Disposables, Australia, Distribution Share by Revenue ($ m), 2007-2008 261
Table 197: Respiratory Measurement Devices, Australia, Distribution Share by Revenue ($ m), 2007-2008 262
Table 198: Sleep Apnea Diagnostic Systems, Australia, Distribution Share by Revenue ($ m), 2007-2008 262
Table 199: Anesthesia and Respiratory Devices, Australia, Company Share by Revenue ($ m), 2008-2008 263
Table 200: Anesthesia Disposables, Australia, Company Share by Revenue ($ m), 2007-2008 264
Table 201: Anesthesia Machines, Australia, Company Share by Revenue ($ m), 2007-2008 265
Table 202: Respiratory Devices, Australia, Company Share by Revenue ($ m), 2007-2008 267
Table 203: Respiratory Disposables, Australia, Company Share by Revenue ($ m), 2007-2008 268
Table 204: Respiratory Measurement Devices, Australia, Company Share by Revenue ($ m), 2007-2008 269
Table 205: Sleep Apnea Diagnostic Systems, Australia, Company Share by Revenue ($ m), 2007-2008 271
Table 206: Anesthesia and Respiratory Devices, Brazil, Overall Revenue ($ m), Historic, 2000-2008 273
Table 207: Anesthesia and Respiratory Devices, Brazil, Overall Revenue ($ m), Forecast, 2008-2015 274
Table 208: Anesthesia and Respiratory Devices, Brazil, Category Volume (Units), Historic, 2000-2008 276
Table 209: Anesthesia and Respiratory Devices, Brazil, Category Volume (Units), Forecast, 2008-2015 277
Table 210: Anesthesia and Respiratory Devices, Brazil, Portfolio Analysis, 2000-2015 278
Table 211: Anesthesia Disposables, Brazil, Distribution Share by Revenue ($ m), 2007-2008 279
Table 212: Anesthesia Machines, Brazil, Distribution Share by Revenue ($ m), 2007-2008 279
Table 213: Respiratory Devices, Brazil, Distribution Share by Revenue ($ m), 2007-2008 280
Table 214: Respiratory Disposables, Brazil, Distribution Share by Revenue ($ m), 2007-2008 280
Table 215: Respiratory Measurement Devices, Brazil, Distribution Share by Revenue ($ m), 2007-2008 281
Table 216: Sleep Apnea Diagnostic Systems, Brazil, Distribution Share by Revenue ($ m), 2007-2008 281
Table 217: Anesthesia and Respiratory Devices, Brazil, Company Share by Revenue ($ m), 2008-2008 282
Table 218: Anesthesia Disposables, Brazil, Company Share by Revenue ($ m), 2007-2008 284
Table 219: Anesthesia Machines, Brazil, Company Share by Revenue ($ m), 2007-2008 285
Table 220: Respiratory Devices, Brazil, Company Share by Revenue ($ m), 2007-2008 286
Table 221: Respiratory Disposables, Brazil, Company Share by Revenue ($ m), 2007-2008 288
Table 222: Respiratory Measurement Devices, Brazil, Company Share by Revenue ($ m), 2007-2008 289
Table 223: Sleep Apnea Diagnostic Systems, Brazil, Company Share by Revenue ($ m), 2007-2008 291
Table 224: Cardinal Health, Inc. Pipeline Products by Equipment Type 297
Table 225: Cardinal Health, Inc. Pipeline Products By Development Stage 298
Table 226: Cardinal Health, Inc. Pipeline Products By Therapy Area 298
Table 227: Ingen Technologies Hires Investment Bank For Its Sale 299
Table 228: Graymark Healthcare Acquires somniTech And somniCare From Avastra Sleep Centres 300
Table 229: Continucare Acquires Professional Sleep Diagnostics From Samuel J. Helmick 301
Table 230: Aircraft Medical Acquires Morpheus Medical 302
Table 231: Air Products Sells Its Three US Healthcare Businesses To Landauer Metropolitan 303
Table 232: Green Hospital Supply To Acquire Central Uni 304
Table 233: Vista Capital And Dan Bowen Acquires Azimuth 305
Table 234: Air Products and Chemicals Sells Its US Healthcare Operations To Walgreen 306
Table 235: Pulmonx Acquires Emphasys Medical 308
Table 236: Ambu Acquires Sleepmate Technologies 309
Table 237: Red Ball Oxygen Acquires PBI Medical 310
Table 238: Inspired Technologies Secures $5.54 In Series B Round Of Financing 311
Table 239: Dormir Secures $12 Million In Series A Round Of Financing 312
Table 240: Inspire Medical Systems Secures $17 Million In Series B Round Of Financing 313
Table 241: Apieron Secures Additional Round Of Series D Financing 315
Table 242: Dormir Secures $8 Million In Growth Capital Financing 316
Table 243: Medbridge Healthcare Secures $10 Million In Financing From Vicente Capital Partners 317
Table 244: Broncus Technologies Secures $4.52 Million In Venture Financing 318
Table 245: Airgas Announces Pricing Of Public Offering Of 4.5% Senior Notes For $400 Million 319
Table 246: Air Products and Chemicals Announces Offering Of 4.375% Senior Notes Due 2019 For $400 Million 321
Table 247: Baxter International Completes Public Offering Of 4.5% Senior Notes For $500 Million 322
Table 248: Apria Healthcare Group Completes Private Placement Of 12.38% Senior Secured Notes For $317 Million 323
Table 249: L&T Announces Public Offering Of $103.78 Million 324
Table 250: CareFusion Announces Pricing Of Private Placement Of 4.125% Senior Notes For $250 Million 325
Table 251: CareFusion Announces Pricing Of Private Placement Of 5.125% Senior Notes For $450 Million 326
Table 252: CareFusion Announces Pricing Of Private Placement Of 6.375% Senior Notes For $700 Million 327
Table 253: Air Liquide Completes Bond Issue Of $560 Million 328

1.2 List of Figures
Figure 1: History of Insulin Delivery Devices 11
Figure 2: Insulin Delivery Devices, Revenue, Global, 2000-2008 14
Figure 3: Insulin Delivery Devices, Global, Revenue ($ m), 2008-2015 16
Figure 4: Insulin Syringes, Global, Revenue ($ m), 2000-2008 18
Figure 5: Insulin Syringes, Global, Revenue ($ m), 2008-2015 19
Figure 6: Insulin Pens, Global, Revenue ($ m), 2000-2008 20
Figure 7: Insulin Pens, Global, Revenue ($ m), 2008-2015 21
Figure 8: Insulin Pumps, Global, Revenue ($ m), 2000-2008 22
Figure 9: Insulin Pumps, Global, Revenue ($ m), 2008-2015 23
Figure 10: Insulin Delivery Devices Cross Country Analysis of Revenue, 2000-2015 26
Figure 11: Insulin Delivery Devices Cross Segment Analysis of Revenue, 2000-2015 28
Figure 12: Opportunity and Unmet Need 31
Figure 13: Strategic Competitive Assessment 34
Figure 14: Global Insulin Delivery Devices Market, Company Share (%), 2008 35
Figure 15: Technology Trends Analytic Framework 40
Figure 16: Technology Trends Analytic Framework -Descriptions 41
Figure 17: Insulin Delivery Devices-Clinical Pipeline by Mode of Insulin Delivery 42
Figure 18: Insulin Delivery Devices Pipeline by Clinical Phase of Development 43
Figure 19: Strategic Competitor Assessment 53
Figure 20: Reimbursement for Insulin Delivery Devices 54
Figure 21: Reimbursement Mix-Insulin Pens 55
Figure 22:  Methodology 58